MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PDSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PDS Biotechnology (PDSB) Earnings Date & Reports

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States... Show more

A.I. Advisor
published Earnings

PDSB is expected to report earnings to rise 17.48% to -24 cents per share on August 13

PDS Biotechnology PDSB Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.10
The last earnings report on May 14 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 645.25K shares outstanding, the current market capitalization sits at 72.22M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PDSB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For PDSB
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
303A College Road
Phone
+1 800 208-3343
Employees
25
Web
https://www.pdsbiotech.com